阿法替尼Gilotrif（afatinib）

[Jimin Pharmaceutical Guide] Afatinib Gilotrif tablets are used for patients with metastatic non-small cell lung cancer.

This product is a tablet, 30 tablets per box, and each tablet is 40 mg. The recommended method of taking is oral, once a day, one tablet each time (40 mg).

Afatinib Gilotrif was developed by Boehringer Ingelheim Pharmaceuticals and is a targeted drug approved for marketing by the US Food and Drug Administration in 2013.